Skip to Content

FRIDAY, 15 DECEMBER 2017, 10:25

Health

Merck’s Keytruda fails pivotal gastric cancer trial

Today at 00:08 AM, via Reuters

(Reuters) – Merck & Co Inc said on Thursday a key late-stage trial testing Keytruda failed to meet its main goal of extending the lives of patients with a type of gastric cancer.

U.S. less generous than European nations with development assistance

Yesterday at 22:01 PM, via Reuters

(Reuters Health) – The U.S. contributes more than any other nation in development assistance for health to low- and middle-income countries, but its generosity falls short when compared in terms of size and wealth, a new study found.

Perrigo lines up bid for Merck’s consumer health unit: sources

Yesterday at 21:40 PM, via Reuters

LONDON/FRANKFURT (Reuters) – Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA’s consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.

Transgender women may get small breasts with hormones

Yesterday at 21:22 PM, via Reuters

(Reuters Health) – Transgender women who take sex hormones to feminize their bodies may not experience as much breast development as they expect, a new European study suggests.

Germany’s Merck to make new bid to enter U.S. MS pill market

Yesterday at 20:28 PM, via Reuters

FRANKFURT (Reuters) – Germany’s Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulators’ concerns about side effects having frustrated its ambitions almost seven years ago.

Healthier baking with simple swaps

Yesterday at 20:00 PM, via CNN

Nutritionist Lisa Drayer shows simple suggestions to cut sugar, fat, and calories from baked goods but still keep them tasty.

Cannabidiol is ‘not likely to be abused,’ WHO says

Yesterday at 19:42 PM, via CNN

Two separate substances, two separate approaches: The World Health Organization endorsed a gentle view of cannabidiol this week while issuing its sternest warning yet against synthetic opioid carfentanil.

Brain cells develop more mutations as we age

Yesterday at 19:18 PM, via Reuters

(Reuters Health) – Brain cells – neurons – develop gene mutations over the course of a lifetime, contributing to normal aging and potentially presenting a target for treatments that stave off dementia and other types of cognitive decline, researchers say.

Hemophilia trial finds promising cure

Yesterday at 19:15 PM, via CNN

A gene-therapy trial by London researchers has seen remarkable success in finding a long-term cure for hemophilia A.

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. ...
  8. 16